Effects of mobile chronic disease management system on prognosis among acute coronary syndrome patients with PCI

W. Pu,Ling Wang
DOI: https://doi.org/10.3760/CMA.J.ISSN.1674-2907.2020.04.013
2020-02-06
Abstract:Objective To explore the effects of mobile chronic disease management system on prognosis among acute coronary syndrome (ACS) patients with percutaneous coronary intervention (PCI) . Methods From February 2016 to May 2017, this study selected 2 212 ACS patients at Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology as subjects by convenience sampling. All of patients were divided into observation group (n=1 127) and control group (n=1 085) with the method of random number table. Control group carried out routine nursing, while observation group implemented routine nursing and health management with the mobile chronic disease management system. This study compared the treatment compliance, medication compliance, risk factors control and incidence of major adverse cardiovascular event (MACE) of patients between two groups. Results There were statistical differences in the active lifestyle modification, medication compliance and reexamine compliance of patients between two groups (P<0.05) . There were also statistical differences in the compliance of clopidogrel, statins, angiotensin converting enzyme inhibitor, nitrates and β-blocker, control of diabetes mellitus, hypertension and hyperlipidemia of patients between two groups (P<0.05) . The incidence of MACE of patients between two groups was statistically different (P<0.01) . Conclusions The mobile chronic disease management system can increase the treatment and medication compliance of ACS patients after PCI, effectively control risk factors and improve prognosis of patients. Key words: Mobile chronic disease management system; Percutaneous coronary intervention; Acute coronary syndrome; Prognosis
Medicine
What problem does this paper attempt to address?